The few published studies in breast tumors have reported (55), however, that Pth1r expression levels were higher in metastatic tumors than in primary tumors in patients with breast cancer and suggested that overexpression of the receptor was the driver for the autocrine actions of PTHrP in bone metastasis. This evidence concerns the gene PTH1R and metastatic neoplasm.